G.O.N. Oosterhof - Concepedia

Author

G.O.N. Oosterhof

Also Known As

G O Oosterhof, G Oosterhof, G. O. N. OOSTERHOF, G. O. N. Oosterhof, G.O. N. Oosterhof, G.O.N. OOSTERHOF, G.O.N. Oosterhof, GON Oosterhof, Gosse O.N. Oosterhof, Hasan

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Canisius-Wilhelmina Ziekenhuis Clinical Research Management

About

G.O.N. Oosterhof is an author at Radboud University Nijmegen specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.1K
2	Health Sciences	3	3	107
3	Cell Biology	2	2	584
4	Anesthesia	1	1	18
5	Biomedical Engineering	1	1	49

G.O.N. Oosterhof

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Rainy Umbas, William B. Isaacs, P P Bringuier, PubMed UrologyProstate CapsuleGenitourinary CancerMedicineRadical Prostatectomy	1994	535
Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. G.J. Jager, Jelle O. Barentsz, G.O.N. Oosterhof, American Journal of Roentgenology	1996	259
Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. G.J. Jager, E T Ruijter, C A van de Kaa, American Journal of Roentgenology	1996	248
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. G.J. Jager, E T Ruijter, C A van de Kaa, Radiology	1997	232
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. Martijn G. Steffens, Otto C. Boerman, Jeannette Oosterwijk‐Wakka, Journal of Clinical Oncology	1997	156
Strontium89 Chloride versus Palliative Local Field Radiotherapy in Patients with Hormonal Escaped Prostate Cancer: A Phase III Study of the European Organisation for Research and Treatment of Cancer Genitourinary Group G.O.N. Oosterhof, J.T. Roberts, T.M. De Reijke, European Urology European OrganisationUrologyRadiation TherapyMedicineBrachytherapy	2003	137
In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Arend Heerschap, G.J. Jager, Marinette van der Graaf, PubMed	1997	132
Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Jelle O. Barentsz, Olette Berger-Hartog, J. Alfred Witjes, Radiology	1998	104
Influence of High-Intensity FocusedUltrasound on the Development ofMetastases G.O.N. Oosterhof, Erik B. Cornel, G. Smits, European Urology	1997	97
Characterization of Human Prostate Cancer, Benign Prostatic Hyperplasia and Normal Prostate by in vitro<sup>1</sup>H and<sup>31</sup>P Magnetic Resonance Spectroscopy Erik B. Cornel, G. Smits, G.O.N. Oosterhof, The Journal of Urology	1993	92

Page 1